Objectives: To evaluate the effect of the red wine phenolic compound (RWPC) dietary supplementation without alcohol interference on: (1) some of the biochemical characteristics of LDL, (2) the oxidative susceptibility of LDL and (3) the antioxidant capacity of total plasma (Pl-AOC). In order to account for discrepancies between the three series of data, the in vitro stability of the association of phenolic compounds and LDL was tested. Design: An intervention study with 20 volunteers. Each served as his own control. Cu 2 -oxidizability of LDL and Pl-AOC were tested on blood samples before and after dietary supplementation. Cu 2 -oxidizability of LDL was also tested by co-incubation in the presence of RWPC or phenolic acids with or without extensive dialysis. Setting: The Laboratory of Lipid Biochemistry and Biology, School of Medicine, and the Laboratory of Metabolic Diseases, Lapeyronie Hospital, University of Montpellier, France. Subjects: Healthy males, nonsmokers and moderate drinkers, submitted to a dietary regimen deprived of vitamin E and C for a period of 10 d before supplementation. They also abstained from alcohol, wine, fruit juices, coffee, tea and cola beverages during this period. Intervention: Six 0.33 g capsulesad (namely two capsules at each meal) of a preparation of red wine phenolic compounds in a dry powder form were given to the volunteers over a period of two weeks. Blood samples were drawn in fasting conditions at day 0 and day 14 of the supplementation period. Results: Supplementation led to: (1) in LDL, a signi®cant increase in vitamin E content (n 20, P 0.01) or vitamin Eatotal fatty acid bis-allylic carbon number ratio (n 20, P 0.006) without modi®cation in the other biochemical characteristics or Cu 2 -oxidizability; (2) in plasma, a signi®cant increase in the antioxidant capacity (n 11, P 0.01). In vitro studies showed that RWPC or sinapic, caffeic or ferulic acids incubated in the presence of LDL increased the protection of the lipoparticle against oxidation (caffeic b sinapic b ferulic). This effect, however, was totally lost after extensive dialysis. Conclusions: The enhancing effect of the RWPC supplementation on Pl-AOC may be due to a phenoliccompound action both in the aqueous phase of plasma and at the surface of lipoprotein particles. Surface location possibly explains the enhancing-sparing effect of supplementation on LDL vitamin E and the absence of effect on dialysed-LDL oxidizability.
Introduction
It is commonly acknowledged that oxidized low-density lipoprotein (ox-LDL) plays an important role in atherogenesis (Steinbrecher et al, 1990) . This is supported particularly by the presence of high quantities of ox-LDL at the site of the atherosclerotic lesion (Yla È-Herttuala et al, 1989) , by the role of ox-LDL in the formation of foam cells and the so-called fatty streak (Ross, 1993 ). An array of additional actions of ox-LDL should also be mentioned, especially: (1) the increase in LDL endothelium permeability ; (2) the activation of endothelium cells resulting in the release of several factors and proteins which promote both monocyte adhesion to endothelium (Quinn et al, 1987; Rajavashisth et al, 1990 ) and monocytederived macrophage transformation into foam cells (Agel et al, 1984) and (3) the stimulation of the superoxide anion production by cells present at the lesion site, this production being probably implicated in the LDL oxidative modi®cation (Li & Cathcart, 1994) . Taken together, these events could be able to initiate, maintain or amplify the atherogenic process.
Dry extracts of red wine contain phenolic compounds that have been shown in vitro to be strong reactive oxygen species scavengers (Bauman et al, 1980; Torel et al, 1986; Roback & Griglewski, 1988) . Red wine-extracted¯avo-noids protect LDL against oxidation in vitro (De Walley et al, 1990; Ne Ágre-Salvayre & Salvayre, 1992; Frankel et al, 1993; Frankel et al, 1995) . Recent studies suggest that people who are fed a rather well de®ned diet usually called the`Mediterranean diet' (Willett et al, 1995) statistically show low incidence of coronary heart disease (CHD) (Renaud & De Lorgeril, 1992) , with an epidemiological link between¯avonoid intake and decreasing risk of CHD (Hertog et al, 1993) . It is postulated that French people are protected against CHD risk by the larger amounts of wine (particularly red wine) they drink as compared to North European or American people. Moreover, decreasing cardiovascular risks occur from the North to the South of France (Ruidavets et al, 1993) . Altogether, these results seem to indicate the anti-atherogenic role of the wine phenolic compounds by preventing ox-LDL formation. Whether the putative cardiovascular protective effect of red wine is brought about by an in vivo action of the RWPC, by the alcoholic component, or by a synergistic action of both is currently open to question.
A bene®cial effect of a moderate red wine consumption has been attributed to ethanol (Rimm et al, 1996) regarding CHD prevention in humans, possibly due to an enhancing effect on the HDL-cholesterol fraction (Criqui & Ringel, 1994) . The aim of the present work was to study the effect of ingestion of a RWPC dry extract, in order to eliminate possible interferences with alcohol, both on the biochemical characteristics and the oxidative susceptibility of LDL, and on the antioxidant capacity of total plasma, in healthy human volunteers. In order to specify why the plasma antioxidant capacity was found to be increased while LDL oxidative susceptibility was not affected, we tested the hypothesis that phenolic compounds can be released from LDL by the extensive dialysis usually included in LDL preparation.
Methods

Chemicals
The RWPC dry powder was prepared from a red wine Cabernet-Sauvignon grape variety and analysed (Institut National de la Recherche Agronomique, Narbonne, France). Brie¯y, this preparation involved three steps: (1) phenolic adsorption on a preparative column; (2) alcoholic desorption and (3) alcoholic eluent concentration by a gentle evaporation. The concentrated residue was then sprayed to obtain a RWPC dry powder which was given to volunteers in 0.33 g capsule form. One liter of red wine contained 190 mgaL (expressed as catechin equivalent or CATeq) of monomeric, dimeric and oligomeric¯avonols (the`catechin proanthocyanidin' fraction) and produced 1.3 g of dry powder or 1.2 g (as CATeq) of total polyphenols. The dry powder contained 112 mgag of catechins proanthocyanidins with only 1.0% of each monomeric form catechin and epicatechin; 64 mgag of total anthocyanins with a major part (36%) of malvidin-3-glucoside; 5 mgag of total¯avonols with 85% of quercetin and quercetin-3-glucoside; and 8.7 mgag of total phenolic acids with 19.5% of caftaric acid.
Sinapic, caffeic and ferulic acids were synthetized by the group of S. Labidalle (Centre d'ênologie, UFR de Pharmacie, Toulouse, France). Horseradish peroxidase (HRP EC 1.11.1.7, type VI A) was from Sigma (Saint Quentin Fallavier, France). Luminol (3-amino phthalhydrazide) and Trolox (6-hydroxy 2,5,7,8-tetramethyl chroman 2-carboxylic acid) were from Aldrich Chemicals (Strasbourg, France).
Subjects
Twenty men (20±45 y old) took part in this study. They were normo-cholesterolemic (3.04±6.64 mmolaL), moderate drinkers and nonsmokers, and none was receiving any pharmacological treatment. For each subject the sequential experiment was as follows: (1) a deprivation period of ten days (day 7 10 to day 7 1) during which vitamin E and C, alcohol, wine, fruit juices, coffee, tea and cola were not allowed to be consumed; (2) a supplementation period of fourteen days (day 0 to day 13) during which the dietary restrictions were maintained and the subjects received six capsules daily (two at each meal) corresponding to 1.98 g of RWPC dry powder. It can be assumed from the above chemical data that 1.98 g of the dry powder contained 222 mg of catechins proanthocyanidins which is usually supplied by 1.17 L of the red wine chosen for this experiment. Thus, the supplementation was equivalent to the consumption of approximately 1 L of wine daily on the basis of the catechin proanthocyanidin fraction. The equivalence of the weight concentration of RWPC with the concentration of a standard gallic acid solution was also determined according to Singleton & Rossi (1965) .
A dietary diary in a questionnaire form was to be ®lled out by each volunteer; it was checked by dieticians of the Laboratory of Metabolic Diseases in order to examine whether the regimen was in compliance with the required restrictions.
Blood samples were drawn by venepuncture on 1 gaL EDTA after overnight fasting at day 0 and day 14. As we decided to assess the Pl-AOC when this work was in progress, we were only able to include 11 of 20 volunteers in this part of the study.
The study was approved by the University of Montpellier Ethics Committee and subjects gave informed, written consent.
LDL oxidation
Plasma lipoproteins (triglyceride rich lipoprotein, TRL, d`1.019 gamL; low density lipoprotein, LDL, d 1.019±1.063 gamL; high density lipoprotein, HDL, d 1.063±1.21 gamL) were isolated by sequential ultracentrifugation (Schumaker & Puppione, 1986 ) in a TFT 65±13 rotor (Kontron Instruments SA, Montigny Le Bretonneux, France) for 4 h per run at 300 000 6 g (65 000 rpm) with density adjustments using potassium bromide (0.71 molaL KBr for LDL isolation). LDL was then extensively dialyzed (with at least a 100a1 volume ratio, repeated three times, at 4 C in the dark, for 24 h) against deoxigenated phosphate-buffered saline (PBS: 10 mmol phosphate bufferaL, 150 mmol NaClaL, pH 7.4) containing 10 mmolaL diethylenetriamine pentacetic acid (DTPA) and sterilized through a 0.22 mm ®lter (Millex-GS, Millipore, Saint Qentin-Yvelines, France). Apoproteins B and A1, lipid fractions and electrochemical detection of vitamin E were measured as previously described (Cachia et al, 1995) . After lipid extraction of LDL, fatty acids were transesteri®ed and analyzed according to the usual laboratory procedure (Sadou et al, 1995) . The total fatty acids were also expressed as the sum of bis-allylic carbon number (Cachia et al, 1995) per LDL particle (as the bisallylic carbon numberaapoB molar ratio). LDL oxidative susceptibility was investigated separately at day 0 and day 14 just after ultracentrifugation and dialysis of the lipoprotein fraction. To do so, we measured the conjugated dienes formed (234 nm absorbance) at 15±20 min intervals during copper chloride (5 mmol Cu LDL solution (0.1 mmol apoBaL) prepared by dilution in air-saturated PBS without DTPA, at 37 C and under magnetic stirring. This allowed us to assess the lag time, the maximal rate and the maximal production of the conjugated dienes , which are indicative of the earliest step in polyunsaturated fatty acid peroxidation. We always respected the same time period from the plasma sample collection to the ®nal LDLoxidizability determination. Under these conditions, for ten consecutive oxidation experiments, the variation coef®-cients of lag time, maximal rate and maximal production of the conjugated dienes were 5.8, 13.7 and 8.4%, respectively. LDL peroxides were analyzed as previously described (El-Saadani et al, 1989) and thiobarbituric acid reactive substances (TBARS) (Lynch & Frei, 1993) were measured as indicative of malondialdehyde and peroxidation break-down product formation from numerous substrates including polyunsaturated fatty acids with more than two double bounds.
Omitting dialysis in the LDL preparation cannot be envisaged because of the presence of Cu 2 -oxidationimpairing EDTA in the blood collection tubes and the high ionic strength provided by potassium bromide. We have checked that this led to non measurable lag times ( b 10 h). Conversely, the particularly long-lasting lag time with non-dialyzed LDL cannot be attributed to higher vitamin E content of LDL as already reported on the basis of vitamin Eatotal protein ratio of LDL (Scheek et al, 1995) . In our conditions and on the basis of vitamin EaapoB ratio we only found a decrease of 11.3% (11.51 AE 1.09 vs 10.29 AE 1.06, n 10; P`0.05) which is of particular interest because such a variation in vitamin E content of LDL particule is known to have a negligible incidence on the LDL resistance to oxidation (Esterbauer et al, 1992) .
To investigate the participation of LDL-associated phenolic compounds in lipoprotein antioxidant protection in vitro, LDL (®nal concentration: 1 mmol apoBaL) was preincubated in 1 mL of PBS at 37 C under N 2 with RWPC (®nal concentrations: 0±20 mgaL) or sinapic, caffeic or ferulic acid (®nal concentrations: 0±100 mmolaL) previously dissolved in ethanoladeionized water (10 : 90, vav) for 1 h. LDL solution was then adjusted to 0.1 mmol apoBaL with PBS and submitted to copper-mediated oxidation without or after usual extensive dialysis. Residual concentration of DTPA ( 0.5 mmolaL) was veri®ed to be without effect on LDL oxidation process.
Sinapic acid distribution into lipoprotein and non-lipoprotein fractions Plasma was incubated under N 2 in the presence of increasing concentrations (0±1 mgaL) of sinapic acid at 37 C for 1 h. TRL, LDL, HDL and`very high density lipoprotein' (VHDL) non lipoprotein (nonLP) fraction (d b 1.21 gamL) were then isolated by sequential ultracentrifugation and the sinapic acid concentration was determined in each lipoprotein fraction by HPLC procedure, before and after usual extensive dialysis.
HPLC assay for sinapic acid Lipoprotein fraction (1 mL) was diluted with PBS containing 10 mmol DTPAaL (1 : 1, vav) and extracted with 4.2 mL of a mixture containing diisopropylethera3N HCl (20 : 1, vav). After evaporation, the dry residue was dissolved in 2 mL of an ethanoladeionized water mixture (10 : 90, vav) and 20 mL was submitted to HPLC using an 150 6 4.6 mm (5 mm diameter particles) column (a C18 inverse phase, Interchim, Montluc Ëon, France). A 50-min linear elution gradient was used with the following mixture: H 2 Oaacetonitrilea1%-H 3 PO 4 , from 20 : 0 : 80 (vavav) at the beginning to 0 : 30 : 70 (vavav) at the end of the elution, at the constant¯ow rate of 1 mLamin. A 1040 A UV-visible diode array detector (Hewlett-Packard, Evry, France) was employed, equipped with a DOS Chemstation. The quantitative measurement was performed by integrating the peak area at 320 nm.
Chemiluminescence assay for plasma antioxidant capacity Pl-AOC was determined by means of a chemiluminescence reaction (Misra & Squatrito, 1982; Henley & Worwood, 1994 ) using a mixture of luminol, hydrogen peroxide and horseradish peroxidase (HRP). The light emission is suppressed in the presence of antioxidative substances acting as radical scavengers and restored when antioxidants are consumed (Whitehead et al, 1992) . The duration of the light suppression Ð indicative of the antioxidant content of the medium Ð was measured with a 1251 Luminometer (LKB, Paris, France). Brie¯y, a 1 gaL stock solution of luminol in 1 molaL NaOH was preparated and diluted daily in a 0.1 molaL Tris-HCl (pH 7.4) buffer for obtaining a 10 mgaL luminol working solution. A 0.1% hydrogen peroxide solution in 10 mmolaL NaOH was daily prepared. A 0.32 gaL stock solution of HRP was prepared and diluted daily in 0.9% NaCl for obtaining a 32 mgaL working solution. A 4 mmolaL Trolox and a 0.1 mGAEaL RWPC stock solutions in ethanol were freshly prepared and diluted in 0.1 mol Tris±HClaL (pH 7.4) buffer for obtaining working solutions. Last, 1a10-diluted plasma solutions in 0.1 molaL Tris-HCl (pH 7.4) buffer were prepared. Chemiluminescence reaction was initiated in the reaction cuvette by addition of the following working solutions: luminol (200 mL), HRP (200 mL), to which 0.1 mol Tris-HClaL (pH 7.4) buffer (180 mL) and either diluted plasma, Trolox or RWPC working solution (20 mL) were ®nally added. The cuvette was placed in the luminometer and 500 mL of the solution of hydrogen peroxide was then added. The Pl-AOC was calculated by determining the time needed to reach 50% of the maximal light emission in the presence of plasma (t pl ) and this time was compared to the Trolox concentration or the RWPC concentration (expressed as m gallic acid equivalent per L or mGAEaL) needed to obtain the same time. This was easily performed by plotting time t tr or t GAE obtained with increasing concentrations of Trolox or RWPC, respectively. The curve obtained was then used to determine the Trolox or RWPC concentration corresponding to t pl . It had previously been veri®ed that ethanol amounts used in the medium had no in¯uence on the light suppression time.
Several light suppression time determinations were performed using the same plasma sample provided by one single volunteer in order to check the reproducability of the luminol±HRP±H 2 O 2 luminescence method. The variation coef®cient was found to be 10.1% for n 20. This means that the probability to ®nd a 15% difference to be signi®cant for a risk of ®rst species a 0.05 was ! 80% for n ! 10.
Plasma samples submitted to chemiluminescence assay had been stored at 7 20 C for 22±40 weeks before use, because sample collection was not performed at the same time. It has been veri®ed that there was no correlation between the decrease in Pl-AOC and the time of conservation (r 2 0.04, regression line with a regression coef®-cient 1.2 mmolaLaweek for both day 0 and day 14 plasma; this value is largely lower than the variation obtained between day 0 and day 14 ascribed to the volunteers' consumption of phenolic compounds). As shown in Table 1 , the increase in vitamin E content was the unique statistical modi®cation (P 0.01) in LDL brought about by the RWPC supplementation. The vitamin E per LDL particle (the vitamin EaapoB molar ratio) was 9.98 AE 0.49 after and 8.63 AE 0.67 before supplementation. In the treated group, LDL particles showed no modi®cation in total lipids (3969.5 AE 194.1 and 3813.5 AE 226.4 molamol of apoB at day 14 and day 0, respectively, namely 4.1%, P 0.2). There was no statistical change in the vitamin Eatotal lipids molar ratio (2.69 AE 0.22 after against 2.62 AE 0.43 before treatment, expressed as mmolamol) together with no signi®cant correlation between vitamin E and total lipids (r 0.03 and 0.36). Table 1 also shows the total fatty acid composition of LDL. No signi®cant change was observed after supplementation, except an increase in stearic acid (the C18 : 0aapoB molar ratio was of 441.5 AE 25.3 vs 389.1 AE 21.4 before supplementation, P 0.02). It is of interest to notice that there was no signi®cant modi®cation in the bis-allylic carbon number per LDL particle, which accounts for the carbon atoms being highly susceptible to the proton abstraction initiating the polyunsaturated fatty acid peroxidation, whereas the vitamin Eabis-allylic carbon number ratio was signi®cantly higher after supplementation (3.89 AE 0.38 vs 3.07 AE 0.25 mmolamol, P 0.006).
Changes in LDL oxidative susceptibility due to supplementation The time-course of conjugated diene formation was similar to that already observed . The lag time, maximal rate and maximal amount of conjugated diene formation were drawn from the curve and reported in Table 2 together with peroxide and TBARS productions. It appears that treatment changed only the conjugated diene production (from 444.6 AE 17.1 at day 0 to 489.5 AE 16.7 at day 14, P 0.01). However, when corrected for bis-allylic carbon number, the conjugated diene production was no longer signi®cantly higher after supplementation (0.19 AE 0.02 vs 0.16 AE 0.01 molamol, P 0.1). There was no signi®cant change in the lag time (65.4 AE 4.1 and 61.4 AE 2.9, P 0.08). No correlation was observed between lag time and LDL vitamin E content (r 0.25 and 0.27 before and after supplementation, respectively).
Consequence of phenolic-compound incubation on oxidative susceptibility of LDL RWPC-incubated LDL without subsequent dialysis was used ®rst in order to assess oxidative susceptibility. As shown by curve A in Figure 1 , lag time and RWPC concentration used for incubation were highly correlated (r 0.98; P`0.001) with a regression coef®cient of 12.2%amgaL. Likewise, sinapic, caffeic or ferulic acidincubated LDL was tested ( Figure 2a and Table 3 ). Phenolic acids also appeared to protect LDL against Cu 2 -mediated oxidation. In addition, a growing protection capacity was found: ferulic acid`sinapic acid`caffeic acid. Curve B in Figure 1 and Figure 2b clearly established that dialysis after LDL incubation resulted in suppression of the relationship between the increased lag time and incubated RWPC or phenolic acids, showing that LDL phenolic compounds were lost by dialysis. Addition of sinapic acid to the total plasma and subsequent isolation of lipoprotein fractions were also performed in order to study a model of phenolic-compound distribution into the different lipoprotein and the non-lipoprotein fractions. Figure 3 shows that the total recovered amount of sinapic acid and the sinapic acid content of each lipoprotein fraction were related to the added amount. In the presence of 100 mgaL of sinapic acid, the total amount recovered after incubation was of 97.5% with 20.8% in VLDL, 10.3% in LDL, 4.7% in HDL and 64.1% in the VHDL nonLP fraction. Only 35% of sinapic acid was associated to lipoproteins with d 1.21 gamL. As mentioned above for RWPC, the sinapic acid part associated to LDL was released during dialysis (not shown). It is to notice that percentage of total recovered amount of sinapic acid decreased with increasing incubated amount (77.2% and 60.6% for 300 mgaL and 1 mgaL, respectively).
Changes in the plasma antioxidant capacity due to supplementation Addition of diluted plasma to the luminescence producing system triggered a rapid inhibition of light emission which was recovered after a time period dependent on the plasma added (see the typical curves shown in Figure 4A ). Figure  4B shows the linear relationship between the light suppression time and the amount of either Trolox (a water soluble tocopherol analogue) or RWPC added to the reaction medium as external standards. Figure 5 illustrates the signi®cant increase in Pl-AOC after RWPC ingestion (170.0 AE 10.4 vs 156.4 AE 10.4 mmolaL and 76.3 AE 7.7 vs 66.0 AE 4.5 mGAEaL for non diluted plasma, when expressed as Trolox concentration or RWPC concentration; P 0.01). The absolute increase appeared to be of 13.6 mmolaL and 10.3 mGAEaL, respectively.
Discussion
It is widely acknowledged that alcohol, phenolic compounds or both may be responsible for a cardiovascular protective effect of wine. Without being exhaustive, it is worth recalling that as early as 1981, Klurfeld & Kritchevski strongly suspected the more bene®cial role of red and white wine consumption as compared with that of all other alcoholic beverages in terms of protection against atherosclerosis in atherogenic rabbits. More recently, in rat the protection of wine against the platelet rebound effect speci®cally due to cessation of alcohol drinking has been attributed to its polyphenolic content, presumably by increasing the plasma antioxidant capacity in vivo (Ruf et al, 1995) . Research into the effect of wine phenolic compounds in humans is therefore a timely avenue of investigation.
The protection against oxidative modi®cation of LDL can be provided either by LDL itself, by the plasma or by both. The approach by in vitro co-incubation of LDL and phenolic compounds (De Whalley et al, 1990; Ne Ágre-Salvayre & Salvayre, 1992; Frankel et al, 1993; Frankel et al, 1995) has been crucial for establishing the protective effect of these substances towards LDL oxidation but is of limited physiological interest because it does not take into account the early stages, namely bioconversion in the intestinal lumen, selective intestinal absorption, which determine to a great part the phenolic forms actually present in the plasma. The purpose of the present paper LDL (1 mmol apoBaL) was incubated at 37 C for 1 h in PBS under N 2 without or with phenolic acids (1±100 mmolaL for sinapic acid, 10± 100 mmolaL for caffeic and ferulic acids). It was then diluted to 1a15 with air-saturated PBS and oxidized by Cu 2 aL. T Lag lag time. was consequently to examine the in vivo`functional' effects of an alcohol-free phenolic supplementation in human volunteers. The question was whether RWPC ingestion over a long term period is ef®cient enough to prevent LDL andaor plasma from oxidation in vivo. Indeed, the absence of suf®ciently reliable and sensitive methods for assessing wine phenolic or wine phenolic-deriving products in the plasma at the beginning of the present study led to the decision to evaluate the functional effect brought about by phenolic-compound ingestion. In order to assess more particularly the remanent antioxidant action of RWPC, blood sampling was made in fasting conditions after two weeks of supplementation.
It can be clearly drawn from the present results that LDL, in its own right, does not gain a higher protection from oxidation (at least, in the assessment conditions used) after a 14 d period of RWPC supplementation. This is true in spite of a 15.7% vitamin E signi®cant enrichment and a more highly signi®cant increase in the vitamin Eabis-allylic carbon molar ratio of LDL, which is expected to be the mark of an improved protection against oxidation (since an antioxidant parameter at the numerator is associated to a pro-oxidant parameter at the denominator). This lack of improved protection is not in agreement with other results (Kondo et al, 1994; Fuhrman et al, 1995) where the action of red or white wine consumption was analyzed using similar LDL preparative procedure. The difference, however, may be explained by the supply of an integrate wine. It is indeed questionable whether wine phenolic compounds are readily absorbed in the absence of alcohol, which is a natural stabilizing agent for polyphenols. Nevertheless, our results agree with those of Sharpe et al (1995) . It is also worth noting that De Rijke et al (1996) reported no difference in LDL protecting effects of red wine as compared with white wine in the particular case of lower alcohol content (3.5%). In this respect, although we have no precise information about proanthocyanidins and anthocyanins of red wine used by these authors, it seems that the daily ingested amounts of`catechins' and¯avonols were similar to those of the present paper and, interestingly, that the amounts present in white wine were extremely low. In these conditions, it is interesting that De Rijke et al. showed no change in LDL vitamin E in relation with LDL cholesterol. It is worth mentioning that our study also supports no signi®cant change in vitamin E as compared to LDL cholesterol (to LDL total lipids as well).
A meta-analysis clearly indicates that a 40% minimal increase in the particle charge of vitamin E is needed to signi®cantly improve the LDL resistance to oxidation (Dieber±Rotheneder et al, 1991; Reaven et al, 1993; Belcher et al, 1993; Suzukawa et al, 1995; Jialal et al, 1995; Princen et al, 1993) . Therefore, the lack of LDLoxidizability effect of the 15.7% increase in vitamin E of LDL in the present study is not surprising. On the other hand, the ®nding that the supplementation led to an enhanced diene production by LDL-oxidation procedure, which was noted to be the only change in measurement of LDL oxidative susceptibility, is likely to be related partly to the slight concomitant change in bis-allylic carbon number.
Regarding the effect of RWPC on the total plasma (namely including lipoproteins in their natural plasma environment) of treated volunteers, it was found a statistically signi®cant increase in Pl-AOC. This is in accordance with the changes reported by others using a slightly different system of chemiluminescence production (Whitehead et al, 1992; Lissi et al, 1995; Maxwell et al, 1994; Whitehead et al, 1995) . The present results, however, add new information because the enhanced antioxidant capacity was achieved by ingesting a phenolic extract and not wine itself, and by using fasting rather than postprandial plasma (see Maxwell et al, 1994; Whitehead et al, 1995) . Thus, they support a real remanence of the antioxidative potency of RWPC. The increase in the antioxidant capacity was equivalent to one third of the vitamin E content of plasma in people who live in the Montpellier, France, area, (namely 42 mmolaL, Cachia et al, 1995) , suggesting that it is not a negligible increase. It is worth noting that this increase was also equivalent to 10.3 mGAEaL which might represent a rather realistic plasma content in polyphenols in cases of red wine consumption. However, we have to keep in mind that only some of the RWPC components (the low molecular weight polyphenols) might be able to pass through the intestinal wall and to be present in the circulating blood. This topic is of crucial importance for the understanding of wine polyphenol action and remains in a great part to be explored.
The present ®nding, however, provides indirect but rather convincing evidence that at least one part of the antioxidant materials from red wine phenolic extracts can be absorbed and enter the plasma in the absence of alcohol. This is in accordance with other studies showing that intestinal absorption of quercetin, quercetin glucosides and phenolic acids (these last ones being present in wine and possibly deriving from¯avonoids by the action of the intestinal micro¯ora) occurs in humans (Hollman et al, 1995) and dogs (S. Labidalle, personal communication).
In order to explain the discrepancy between the results obtained with isolated LDL and total plasma, we decided to proceed in vitro LDL oxidation after incubation in the presence of RWPC or phenolic acids present in red wine. One dialysis was performed after incubation and just before the oxidation procedure, or this dialysis was omitted. The results clearly showed that these phenolic compounds, without dialysis, readily increased the defense of the lipoparticle against the oxidative stress. The higher protection provided by caffeic acid (3,4-dihydroxy-cinnamic acid) as compared with sinapic and ferulic acids (4-hydroxy-3,5-dimethoxy-cinnamic and 4-hydroxy-3-methoxy-cinnamic acids, respectively) underlines the negative effect of the presence of methoxyl group(s) on the aromatic cycle near the phenyl hydroxyl in preventing oxidation (Rafat et al, 1987; Nardini et al, 1995) as well as the positive effect of the orthodiphenol con®guration. However, the antioxidative protection of phenolic compounds was totally lost after extensive LDL dialysis. This strongly suggests that RWPC or phenolic acids are loosely associated to LDL, possibly remaining at least partially, by virtue of their mainly hydrophilic properties, at the surface of the particle where they could achieve their protective action. This is at variance with another work (Fuhrman et al, 1995) which found that dialysis before the oxidation procedure did not affect the phenolic content of LDL as assessed by a procedure which unfortunately interferes with proteins. We propose that the effect of dialysis presently shown explains why LDL (once isolated) and original plasma have different antioxidative capacities. Some ®nd-ings of our group (unpublished data) have recently been obtained using gel chromatography which entirely con®rm that phenolic compounds are easily released from LDL particles. In addition, the data on the sinapic acid partition into plasma fractions also show that this compound is mainly located in the protein, protein-rich lipoprotein (d b 1.21 gamL) and aqueous part of plasma.
It could be assumed that¯avonoids play a role similar to that of vitamin C at the surface of LDL particles (Niki, Figure 4 Typical time course of light emission with 1a10 diluted plasma from one subject before (day 0) and after (day 14) RWPC supplementation (A) and linear relationship between the time of light suppression (t) and the trolox or RWPC concentration (B). 20 mL of plasma once diluted at 1a10 in PBS or 20 mL of standard solutions (trolox or RWPC) was added to the luminescence producing system (luminolaHRPaH 2 O 2 ). The time of plasma (t pl ) or standards (t) light suppression was assessed by the time needed to reach 50% of the maximum value. Trolox or RWPC concentrations were expressed as mmolaL or mGAEaL, respectively. 1986; Frei, 1991) by regenerating the reduced form of vitamin E from its oxidized form chromanoxyl and by generating phenoxyl radicals Ph-O (Belyakov et al, 1995) , benzofuranic substances and other new radical-scavenging phenolic compounds (Tsuda et al, 1996) . A sparing effect of tannins toward the plasma vitamin E of moderate drinkers has already been suggested from examination of epidemiological data (Leconte et al, 1994) . Based on the present increase in LDL vitamin E, it appears that the sparing effect may essentially involve the LDL particle as HDL was not modi®ed. Moreover, it also suggests that the increase in Pl-AOC is of physiological relevance in terms of LDL antioxidative protection.
In spite of a better understanding of the¯avonoid reactions leading to an antioxidative protection in physiological conditions, further investigations are still needed to determine which forms of¯avonoid-derived products in vivo would be effective in humans in preventing oxidative deleterious alterations, which are assumed to result in an anti-atherogenic effect (work in progress in a collaborative project).
